AUM CAPITAL (Your trust is our wealth)

facebook twitter linkedin
Careers

Market info

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1415.3061.45 (+4.54 %)
PREV CLOSE (Rs.) 1353.85
OPEN PRICE (Rs.) 1354.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 325323
TODAY'S LOW / HIGH (Rs.)1354.55 1418.00
52 WK LOW / HIGH (Rs.)1165.55 1672.2
NSE1415.7063.9 (+4.73 %)
PREV CLOSE( Rs. ) 1351.80
OPEN PRICE (Rs.) 1372.00
BID PRICE (QTY) 1415.70 (61)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3368853
TODAY'S LOW / HIGH(Rs.) 1370.60 1418.20
52 WK LOW / HIGH (Rs.)1165.7 1673
Home Market Info & ResearchCompany ProfileSmart Quotes
BSE NSE
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
4559.98
Dividend Yield(%)
0.92
TTM EPS (Rs.)
43.51
P/E Ratio
32.53
Book Value (Rs.)
422.59
Face Value (Rs.)
2
MCap (Rs. in Mn)
1143343.48
Price/Earning (TTM)
27.39
Price/Sales (TTM)
6.02
Price/Book (MRQ)
3.35
PAT Margin (%)
17.52
ROCE (%)
14.04
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Achin Gupta - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 41916000

Website : www.cipla.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
16Jun Grant Of Stock Options And The Employ
Grant of Stock Options and Employee Stock Appreciation Rights (ESARs)
13May Cipla’s consolidated net profit falls
Cipla has reported results for the fourth quarter (Q4FY26) and year ende..
13May Cipla informs about investor presentat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
more
QTR Mar 26 ANNUAL 26
Net Profit3846.435151.8
Gross Profit 5224.8 46359.4
Operating Profit 7783.3 55890.4
Net Sales 42099.8 189799.5
more
Rs. in Millions
Astrazeneca Pharma (BSE)
 8556.55 (1.78%)
M.Cap (Rs. in Cr)21391.38
Ajanta Pharma (BSE)
 3188.75 (4.12%)
M.Cap (Rs. in Cr)39838.85
Mankind Pharma (BSE)
 2537.05 (4.95%)
M.Cap (Rs. in Cr)104779.14
NGL Fine-Chem (BSE)
 3156.15 (2.67%)
M.Cap (Rs. in Cr)1949.88
PROMOTERS
29.21%
MUTUAL FUNDS/UTI
18.66%
NON-INSTITUTION
16.26%
FI/BANKS/INSURANCE
11.29%
GOVERNMENT
0%
FII
0%
more
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances